Aligos Therapeutics ALGS
NASDAQ ALGS
$6.73 +0.29 (+4.53%)
As of: Aug 21, 2026 · 1:29 PM EDT

Aligos Therapeutics (ALGS) Current Deferred Revenue (2020 - 2025)

Aligos Therapeutics' (ALGS) quarterly Current Deferred Revenue came in at $168000.0 in Q3 2025, down 70.98% on a QoQ basis from $579000.0 in Q2 2025.

Aligos Therapeutics (ALGS) Current Deferred Revenue (2020 - 2025) Analysis & Trends

Aligos Therapeutics (ALGS) has 6 years of Current Deferred Revenue data on file, last reported at $168000.0 in Q3 2025.

  • Quarterly Current Deferred Revenue changed N/A year-over-year to $168000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $168000.0 (changed N/A YoY) and the FY2024 annual result came in at $151000.0, down 88.46% from the prior year.
  • Current Deferred Revenue slipped to $168000.0 in Q3 2025, from $579000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $15.1 million in Q1 2022 to a low of $151000.0 in Q4 2024.
  • A 5-year average of $6.1 million and a median of $6.6 million in 2021 frame the typical range for Current Deferred Revenue.
  • Annual changes were most pronounced in 2022 — Current Deferred Revenue soared 98.75% — and 2024, when it plunged 88.46%.
  • Tracing ALGS's Current Deferred Revenue over 5 years: stood at $7.6 million in 2021, then gained by 14.42% to $8.7 million in 2022, then sank by 85.04% to $1.3 million in 2023, then sank by 88.46% to $151000.0 in 2024, then advanced by 11.26% to $168000.0 in 2025.
  • The last three Current Deferred Revenue figures came in at $168000.0 (Q3 2025), $579000.0 (Q2 2025), and $151000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.20 Bn 131.35 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.09 Bn 78.10 Bn 3.93 Bn
3 Argenx Se 65.25 Bn 60.07 Bn 1.37 Bn
4 Moderna 59.04 Bn 53.90 Bn 52.00 Mn
5 BeOne Medicines 42.04 Bn 36.94 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.61 Bn 28.30 Bn 992.69 Mn
7 BioNTech SE 28.04 Bn 9.65 Bn 668.28 Mn
8 Insmed 27.50 Bn 26.33 Bn 358.27 Mn
9 Royalty Pharma 27.34 Bn 26.50 Bn -
10 Aligos Therapeutics 70.20 Mn 39.76 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 168,000.00
Jun 30, 2025 579,000.00
Dec 31, 2024 151,000.00
Dec 31, 2023 1.31 Mn
Sep 30, 2023 2.09 Mn
Jun 30, 2023 4.10 Mn
Mar 31, 2023 6.56 Mn
Dec 31, 2022 8.74 Mn
Sep 30, 2022 10.73 Mn
Jun 30, 2022 13.13 Mn
Mar 31, 2022 15.07 Mn
Dec 31, 2021 7.64 Mn
Sep 30, 2021 6.64 Mn
Jun 30, 2021 6.81 Mn
Mar 31, 2021 7.58 Mn
Dec 31, 2020 7.89 Mn